Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Extracellular leucine-rich repeat and fibronectin type III domain-containing protein 1 (ELFN1) is a postsynaptic adhesion molecule predominantly expressed in the nervous system, notably in the cortex, hippocampus, and globus pallidus. ELFN1 contains an extracellular domain with six leucine-rich repeats (LRRs), a fibronectin type-III (FN3) domain, a transmembrane domain, and an extended intracellular segment. Functionally, ELFN1 plays an integral role at excitatory synapses onto certain interneurons, modulating the timing and probability of neurotransmitter release by organizing presynaptic group III metabotropic glutamate receptors (mGluRs) in a trans-synaptic manner, acting as an allosteric modulator of these receptors. ELFN1 also inhibits the activity of protein phosphatase 1 (PP1) complexes, directly impacting synaptic circuit dynamics and potentially overall neural plasticity. Mutations or dysregulation of ELFN1 have been implicated in neurological disorders such as Joubert syndrome 17 and other synaptopathies.
Allosteric modulation of group III metabotropic glutamate receptors (mGluR4, mGluR6, mGluR7, mGluR8); Synaptic adhesion and modulation of presynaptic neurotransmitter release probability; Inhibition of protein phosphatase 1 complexes
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Extracellular leucine-rich repeat and fibronectin type III domain-containing protein 1 (ELFN1).